Yes $52 million. That's a tremendous amount of money for a biotech. Combined with overwhelming insider ownership and buying. That's enough cash to last well into late next year and very likely through NDA filing for Ganetespib.
it may seem to be a lot of money,but bios can burn through cash rather quickly,im heavy into one that has more than 80 mil. and it is becoming a concern that they may dilute further mid 2012, thats the risk factor you need to keep in mind when you lay your cash down on a stock like snta, sooner or later cash will indeed become an issue............how soon,im starting to think it may be sooner than most of us would like,keep it real!